Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.34 |
| ▸ | KDM4A | O75164 | 1/20 | 0.34 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.34 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.30 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7754927 | 0.92 | LMNA (0.39) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL2047008 | 0.88 | LMNA (0.39) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL31365936 | 0.88 | LMNA (0.39) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL7758897 | 0.88 | LMNA (0.39) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL9319584 | 0.88 | LMNA (0.39) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL31365935 | 0.88 | LMNA (0.39) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL15563205 | 0.88 | LMNA (0.39) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL7759645 | 0.88 | LMNA (0.39) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL5652783 | 0.88 | LMNA (0.39) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL6239055 | 0.86 | LMNA (0.37) | KDM4CKDM4APHF8KDM2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003105806-A1 | STABILIZED RETINOL FOR COSMETIC DERMATOLOGICAL, AND PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF | SALVONA L.L.C. (US) | 2003-12-24 | — | — | WO | claimed |
| US-20030232091-A1 | Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof | SHEFER ADI (US) | 2003-12-18 | — | — | US | claimed |
| WO-2023205439-A2 | SKIN BARRIER PROTECTIVE DELIVERY SYSTEMS AND METHODS THEREOF | BOBO LABS INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| US-20220409518-A1 | EMU Oil In Combination With Other Active Ingredients For Treating Skin Imperfections | DESAI, KETAN | 2022-12-29 | — | — | US | disclosed |
| US-20190358327-A1 | BIOPHOTONIC COMPOSITIONS COMPRISING LICHEN EXTRACT AND THEIR USE TO TREAT SKIN DISORDERS | KLOX TECHNOLOGIES INC. (CA) | 2019-11-28 | — | — | US | disclosed |
| EP-3558374-A1 | BIOPHOTONIC COMPOSITIONS COMPRISING LICHEN EXTRACT AND THEIR USE TO TREAT SKIN DISORDERS | Klox Technologies Inc. (CA) | 2019-10-30 | — | — | EP | disclosed |
| EP-3366274-A1 | COSMETIC BIOPHOTONIC COMPOSITIONS | KLOX Technologies, Inc. (CA) | 2018-08-29 | — | — | EP | disclosed |
| WO-2018112666-A1 | BIOPHOTONIC COMPOSITIONS COMPRISING LICHEN EXTRACT AND THEIR USE TO TREAT SKIN DISORDERS | KLOX TECHNOLOGIES INC. (CA) | 2018-06-28 | — | — | WO | disclosed |
| US-20170326378-A1 | COSMETIC BIOPHOTONIC COMPOSITIONS | KLOX TECHNOLOGIES INC. (CA) | 2017-11-16 | — | — | US | disclosed |
| US-20170304187-A1 | EMU Oil In Combination With Other Active Ingredients For Treating Skin Imperfections | DESAI, KETAN | 2017-10-26 | — | — | US | disclosed |
| US-9757324-B2 | Emu oil in combination with other active ingredients for treating skin imperfections | DESAI, KETAN | 2017-09-12 | — | — | US | disclosed |
| US-20050271692-A1 | Topical cosmetic compositions | COSMECEUTIC SOLUTIONS PTY. LTD. | 2005-12-08 | — | — | US | disclosed |
| EP-1534214-A1 | TOPICAL COSMETIC COMPOSITIONS | Cosmeceutic Solutions Pty Ltd (AU) | 2005-06-01 | — | — | EP | disclosed |
| WO-2005046574-A2 | COMPOSITIONS CONTAINING MELON EXTRACTS | GUTHY-RENKER CORPORATION (US) | 2005-05-26 | — | — | WO | disclosed |
| US-20050025737-A1 | Compositions containing melon extracts | SEBAGH JEAN LOUIS (FR) | 2005-02-03 | — | — | US | disclosed |
| WO-2004000242-A1 | TOPICAL COSMETIC COMPOSITIONS | COSMECEUTIC SOLUTIONS PTY LTD (AU) | 2003-12-31 | — | — | WO | disclosed |
| WO-2003105806-A1 | STABILIZED RETINOL FOR COSMETIC DERMATOLOGICAL, AND PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF | SALVONA L.L.C. (US) | 2003-12-24 | — | — | WO | disclosed |
| US-20030232091-A1 | Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof | SHEFER ADI (US) | 2003-12-18 | — | — | US | disclosed |
| US-20030039668-A1 | Trans dermal skin care | NEO TECH DEVELOPMENT COMPANY, L.L.C. | 2003-02-27 | — | — | US | disclosed |
| US-6338855-B1 | DISPOSABLE CLEANING SHEETS WITH FROTHS AND SURFACTANTS | THE PROCTER & GAMBLE COMPANY | 2002-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050271692-A1 | Topical cosmetic compositions | CUTA, MITF, DSG1 | KDM4C 2705/4885KDM4A 3130/4885PHF8 118/4885 |
| US-20030232091-A1 | Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof | RBP4, RBP1, RARA | KDM4C 2351/4885KDM4A 2320/4885PHF8 852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.